文献速递垂体与肾上腺疾病

西班牙语患者直接参与的初级醛固酮增多症检测项目实施

Implementation of a Spanish-language, direct-to-patient primary aldosteronism testing program.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

本研究在波士顿、纽约、迈阿密、休斯顿和洛杉矶/圣地亚哥招募西班牙语成人开展直接面向患者的初级醛固酮增多症(PA)检测,155名参与者中77.4%英语能力有限,30.3%检测阳性;阳性且随访者中10.3%接受进一步检测、10.3%启动盐皮质激素受体拮抗剂,语言匹配的检测项目有助于解决西班牙裔/拉丁裔人群高血压和PA高负担问题。

要点

  • 西班牙语直接面向患者的PA检测项目在155名参与者中识别出30.3%的PA阳性率
  • 阳性且随访者中仅10.3%接受进一步检测、10.3%启动盐皮质激素受体拮抗剂治疗
  • 参与者报告就医可及性和临床医生对结果的忽视是临床行动障碍

核心结论

  • 西班牙语直接面向患者的PA检测项目有效触达患者,在超过30%的参与者中识别出可能的PA,并影响了下游诊疗。
  • 语言匹配的PA检测举措有助于应对美国西班牙裔/拉丁裔人群中高血压和PA的高患病率。

研究设计与样本

  • 研究从波士顿、纽约、迈阿密、休斯顿和洛杉矶/圣地亚哥招募有PA检测指征的西班牙语成人。
  • 参与者接受西班牙语虚拟病史回顾和当地采血进行PA检测,检测解读传达给患者和临床医生,并在6个月时随访。
  • 主要结局为PA检测阳性频率,次要结局包括临床PA检测、醛固酮靶向治疗启动和生活质量。

主要发现

  • 研究人群(N=155)西班牙语流利,77.4%报告英语能力有限。
  • 30.3%的参与者PA检测阳性。
  • 主要PA检测指征为早发高血压或卒中家族史以及睡眠呼吸暂停。
  • 在检测阳性且提供随访的参与者(n=29)中,10.3%接受了额外PA检测,10.3%启动了盐皮质激素受体拮抗剂。
  • 参与者提及就医可及性和临床医生对结果的忽视是临床行动的障碍,但研究参与被 positively 评价为增强健康意识和研究参与兴趣。

临床怎么用

  • 语言 concordant 的直接面向患者PA检测项目可有效筛查西班牙语人群中的PA。
  • 需关注检测阳性后临床行动障碍,包括就医可及性和临床医生对检测结果的忽视。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Primary aldosteronism (PA) is a common, targetable cause of hypertension and cardiovascular risk, but <2% of eligible patients are tested, and Hispanic/Latino patients are underrepresented in PA research and care. OBJECTIVE: We expanded a nationwide, direct-to-patient PA testing program to reach Spanish-speaking adults. METHODS: Spanish-speaking adults with PA testing indications were recruited from Boston, New York, Miami, Houston, and Los Angeles/San Diego. Participants underwent virtual medical history review in Spanish and local phlebotomy for PA testing, with laboratory interpretations communicated to patients and clinicians. Participants were followed up at 6 months. The primary outcome was the frequency of a positive PA test. Secondary outcomes included clinical PA testing, initiation of aldosterone-targeted therapies, and quality of life. RESULTS: The study population (N = 155) spoke fluent Spanish, with 77.4% reporting limited English proficiency. Of the participants, 30.3% tested positive for PA. Leading PA testing indications were family history of premature hypertension or stroke and sleep apnea. Among participants who tested positive and provided follow-up (n = 29), 10.3% underwent additional testing for PA, and 10.3% started a mineralocorticoid receptor antagonist. Participants cited access to care and clinician dismissal of results as barriers to clinical action; however, study participation was positively rated to enhance health awareness and interest in research participation. CONCLUSION: This Spanish-language, direct-to-patient PA testing program effectively reached patients for testing, identified possible PA in over 30%, and influenced downstream care. Language-concordant PA testing initiatives can help to address the high prevalence of hypertension and PA in the US Hispanic/Latino population.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Ferrebus A, Tsai LC, Abel EE, et al. Implementation of a Spanish-language, direct-to-patient primary aldosteronism testing program. J Clin Endocrinol Metab. 2026. PMID: 41370229. doi:10.1210/clinem/dgaf663

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。